A drug with the SMILES CC[C@@H](C)C(NC(=O)OC(C)(C)C)c1cn([C@@H](Cc2cc3ccccc3[nH]2)C(=O)N2CCN(C(=O)OC(C)(C)C)CC2)nn1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -13.401%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CC[C@@H](C)C(NC(=O)OC(C)(C)C)c1cn([C@@H](Cc2cc3ccccc3[nH]2)C(=O)N2CCN(C(=O)OC(C)(C)C)CC2)nn1
CC[C@@H](C)C(NC(=O)OC(C)(C)C)c1cn([C@@H](Cc2cc3ccccc3[nH]2)C(=O)N2CCN(C(=O)OC(C)(C)C)CC2)nn1
tert-butyl 4-[(2S)-3-(1H-indol-2-yl)-2-[4-[(2R)-2-methyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]butyl]triazol-1-yl]propanoyl]piperazine-1-carboxylate